Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Fungal infection corticosteroids

There are hundreds of topical steroid preparations that are available for the treatment of skin diseases. In addition to their aforementioned antiinflammatory effects, topical steroids also exert their effects by vasoconstriction of the capillaries in the superficial dermis and by reduction of cellular mitosis and cell proliferation especially in the basal cell layer of the skin. In addition to the aforementioned systemic side effects, topical steroids can have adverse local effects. Chronic treatment with topical corticosteroids may increase the risk of bacterial and fungal infections. A combination steroid and antibacterial agent can be used to combat this problem. Additional local side effects that can be caused by extended use of topical steroids are epidermal atrophy, acne, glaucoma and cataracts (thus the weakest concentrations should be used in and around the eyes), pigmentation problems, hypertrichosis, allergic contact dermatitis, perioral dermatitis, and granuloma gluteale infantum (251). [Pg.446]

Neutrophil Segs 40%-60% Bands 3%-5% Phagocytic Leukocytosis Bacterial infections Fungal infections Physiologic stress Tissue injury (e.g. myocardial Infarction) Medications (e.g. corticosteroids) Leukopenia Long-standing infection Cancer Medications (e.g., chemotherapy)... [Pg.1024]

Sofradex contains dexamethasone, framycetin and gramicidin and is indicated in otitis externa. Canesten contains clotrimazole and is indicated for fungal infections and may be used in otitis externa where a fungal infection is suspected. Nasonex contains mometasone, a corticosteroid, and is used in nasal allergy. [Pg.159]

Systemic fungal infections hypersensitivity to the drug IM use in ITP administration of live virus vaccines (eg, smallpox) in patients receiving immunosuppressive corticosteroid doses (see Warnings). [Pg.262]

Infections Corticosteroids may mask signs of infection, and new infections may appear during their use. There may be decreased resistance and inability of the host defense mechanisms to prevent dissemination of the infection. Restrict use in active tuberculosis to cases of fulminating or disseminated disease in which the corticosteroid is used for disease management with appropriate chemotherapy. Corticosteroids may exacerbate systemic fungal infections and may activate latent amebiasis. [Pg.262]

Infections Localized fungal infections with Candida albicans or Aspergillus niger have occurred in the mouth, pharynx, and occasionally in the larynx. The incidence of clinically apparent infection is low, and may require treatment with appropriate antifungal therapy or discontinuance of aerosol steroid treatment. Use inhaled corticosteroids with caution, if at all, in patients with active or quiescent tuberculous infection of the respiratory tract, untreated systemic fungal, bacterial, parasitic or... [Pg.752]

Contraindications Hypersensitivity to any corticosteroid or its components, persistently positive sputum cultures ior Candida albicans, primary treatment of status asth-maticus, systemic fungal infections, untreated localized infection involving nasal mu-... [Pg.159]

Contraindications Hypersensitivity to corticosteroids, administration of live virus vaccine, peptic ulcers (except in life-threatening situations), systemic fungal infection... [Pg.306]

Contraindications Administration of live virus vaccines, especially smallpox vaccine hypersensitivity to corticosteroids or tartrazine peptic ulcer disease (except life-threatening situations) systemic fungal infection Topical Marked circulation impairment... [Pg.1260]

Candida albicans) after they received high doses of cytotoxic, immunosuppressive, or corticosteroid drugs. By monitoring the D/L arabinitol ratio, fungal infections can be diagnosed early enough to permit effective—in some cases, life-saving—treatment. The separation of trifluoroacetylated arabinitol is depicted in Fig. 14,... [Pg.124]

The appearance in debilitated patients of opportunistic fungal infections after therapy with antibiotics and corticosteroids or other immunosuppressive agents continues to be emphasized.Since these medicaments are vital in procedures such as the transplantation of organs, antifungal agents become more important for prophylactic or therapeutic use. All indications are that they will continue to increase in importance. [Pg.129]

Despite case reports of response to treatment with corticosteroids, larger studies have not shown any outcome benefit. Currently, accepted treatment options are limited to supportive care and prevention and treatment of infection. There is a report of three BMT recipients with IPS whose lung function improved following etanercept administration (13). Lung transplant may offer a therapeutic option for selected patients. Although the pneumonitis resolves in about 31%, the clinical course of IPS is often comphcated by viral and fungal infections, pneumothorax, pneumomediastinum, subcutaneous emphysema, pulmonary fibrosis, and autoimmune polyserositis (5). The case fatality of IPS is... [Pg.564]

Fungal Infections Although fxmgal upper respiratory tract colonisation and infections are known adverse effects of inhaled corticosteroids, only recently a fxmgal lower respiratory fracf infection, and more specifically a case of Candida pneumonia in a neonate, was attributed to ICS [11 ]. The neonate received inhaled beclomethasone therapy (400 xg, six times a day) for bronchopulmonary dysplasia. After 20 days of freafment, the patient developed a lower respiratory tract infection. Klebsiella pneumoniae was isolated in fhe fracheal aspirate and treated with amnxirillin-clavulanate without clinical improvement. A week later, bronchoscopy was performed and extended candidiasis was found and treated successfully with fluconazole. Candida pneumonia secondary to airway colonisation is rare and in this case, it was likely provoked by the ICS treatment. [Pg.243]

Fungal infections A case of cryptococ-cal meningitis complicating corticosteroid therapy has been reported (74 ). [Pg.285]

Serious adverse events occur in up to 6% of patients with anti-TNF therapy. The most important adverse effect of these drugs is infection due to suppression of the ThI inflammatory response. This may lead to serious infections such as bacterial sepsis, tuberculosis, invasive fungal organisms, reactivation of hepatitis B, listeriosis, and other opportunistic infections. Reactivation of latent tuberculosis, with dissemination, has occurred. Before administering anti-TNF therapy, all patients must undergo purified protein derivative (PPD) testing prophylactic therapy for tuberculosis is warranted for patients with positive test results. More common but usually less serious infections include upper respiratory infections (sinusitis, bronchitis, and pneumonia) and cellulitis. The risk of serious infections is increased markedly in patients taking concomitant corticosteroids. [Pg.1329]

Topical corticosteroids are of no use for urticarial conditions and are contraindicated in infection, e.g. fungal, herpes, impetigo, scabies, because the infection will exacerbate and spread. Where appropriate, an adrenal steroid formulation may include an antimicrobial, e.g. miconazole, fusidic acid, in infected eczema. [Pg.303]


See other pages where Fungal infection corticosteroids is mentioned: [Pg.338]    [Pg.846]    [Pg.1217]    [Pg.1459]    [Pg.434]    [Pg.134]    [Pg.390]    [Pg.465]    [Pg.336]    [Pg.639]    [Pg.421]    [Pg.108]    [Pg.109]    [Pg.160]    [Pg.170]    [Pg.244]    [Pg.84]    [Pg.326]    [Pg.2133]    [Pg.2177]    [Pg.2183]    [Pg.2194]    [Pg.22]    [Pg.338]    [Pg.1050]    [Pg.1052]    [Pg.42]    [Pg.1218]    [Pg.74]   
See also in sourсe #XX -- [ Pg.285 ]




SEARCH



Infection fungal

© 2024 chempedia.info